SC
GILD icon

Stralem & Co’s Gilead Sciences GILD Stock Holding History

Stralem & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$6K Hold
78
– – ﹤0.01% 71
2020
Q1 		$6K Buy
+78
New +$5.39K ﹤0.01% 67
2019
Q1 		– Sell
-9,400
Closed -$588K – 42
2018
Q4 		$588K Hold
9,400
– – 0.28% 45
2018
Q3 		$726K Buy
9,400
+700
+8% +$52.9K 0.22% 46
2018
Q2 		$616K Hold
8,700
– – 0.18% 45
2018
Q1 		$656K Sell
8,700
-4,000
-31% -$318K 0.13% 45
2017
Q4 		$910K Buy
12,700
+600
+5% +$45.6K 0.15% 41
2017
Q3 		$980K Sell
12,100
-700
-5% -$53.5K 0.14% 46
2017
Q2 		$906K Buy
12,800
+3,200
+33% +$213K 0.11% 46
2017
Q1 		$652K Hold
9,600
– – 0.08% 47
2016
Q4 		$687K Buy
9,600
+300
+3% +$22.3K 0.08% 48
2016
Q3 		$736K Buy
9,300
+300
+3% +$24.4K 0.09% 48
2016
Q2 		$751K Hold
9,000
– – 0.09% 48
2016
Q1 		$827K Buy
9,000
+700
+8% +$63.1K 0.09% 46
2015
Q4 		$840K Hold
8,300
– – 0.09% 47
2015
Q3 		$815K Sell
8,300
-100
-1% -$11.1K 0.07% 49
2015
Q2 		$983K Hold
8,400
– – 0.07% 47
2015
Q1 		$824K Sell
8,400
-2,000
-19% -$203K 0.05% 47
2014
Q4 		$980K Sell
10,400
-100
-1% -$10.3K 0.05% 43
2014
Q3 		$1.12M Sell
10,500
-2,100
-17% -$206K 0.04% 41
2014
Q2 		$1.04M Sell
12,600
-17,700
-58% -$1.38M 0.04% 41
2014
Q1 		$2.15M Buy
30,300
+1,900
+7% +$149K 0.07% 40
2013
Q4 		$2.13M Buy
28,400
+5,700
+25% +$397K 0.06% 39
2013
Q3 		$1.43M Sell
22,700
-3,000
-12% -$179K 0.04% 40
2013
Q2 		$1.32M Buy
+25,700
New +$1.34M 0.04% 41

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Stralem & Co's GILD Position: Q2 2020 in Review

Stralem & Co held its Gilead Sciences (GILD) position steady in Q2 2020 at 78 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #71.

Stralem & Co first reported a position in GILD in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.15M in Q1 2014. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Stralem & Co held 78 shares of Gilead Sciences worth $6K as of Q2 2020.
  • Stralem & Co left its Gilead Sciences share count unchanged in Q2 2020.
  • Gilead Sciences made up ﹤0.01% of Stralem & Co's portfolio in Q2 2020, its #71 holding.
  • Stralem & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 25 quarters since.
  • Stralem & Co's Gilead Sciences position peaked at $2.15M in Q1 2014.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Stralem & Co's 13F filing for Q2 2020, filed 20 Jul 2020.